Compare CDMOs with rare disease manufacturing expertise for orphan drugs, enzyme replacement therapies, gene therapies, and ultra-small batch production. Filter by modality, scale, and regulatory experience.
90 companies listed
United States
GeneFab is a US-based contract research, development, and manufacturing organization (CRDMO) focused on cell and gene therapies, operating from Alameda, California. The company acquired Senti Bio's production facility and specializes in lentiviral, retroviral, and adeno-associated viral vector manufacturing. GeneFab provides end-to-end services from genetic design and process development through cGMP clinical and commercial manufacturing.
United States
Genezen (USA) is a leading cell and gene therapy CDMO founded in 2014, specializing in lentiviral, retroviral, and adeno-associated viral (AAV) vector manufacturing. The company operates a 60,000 sq ft cGMP facility in Fishers, Indiana and an 86,000 sq ft licensed facility in Lexington, Massachusetts. Genezen provides end-to-end services from preclinical through commercial manufacturing, with FDA registration and established manufacturing partnerships.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.